Literature DB >> 2210458

Anomalous short plasma elimination half life in a patient intoxicated with bismuth subcitrate.

A J McLean, S Islam, J R Lambert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2210458      PMCID： PMC1378677          DOI： 10.1136/gut.31.9.1086

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  18 in total

1.  [Iatrogenic myoclonic encephalopathies caused by bismuth salts].

Authors:  P Loiseau; P Henry; P Jallon; M Legroux
Journal:  J Neurol Sci       Date:  1976-02       Impact factor: 3.181

2.  Pathogenicity of Campylobacter pylori in the upper gastrointestinal tract--implications for modern therapy.

Authors:  J R Lambert; A J McLean
Journal:  Med J Aust       Date:  1989-08-07       Impact factor: 7.738

3.  Neuropsychiatric symptoms following bismuth intoxication.

Authors:  M P Weller
Journal:  Postgrad Med J       Date:  1988-04       Impact factor: 2.401

Review 4.  Influence of ulcer healing agents on ulcer relapse after discontinuation of acute treatment: a pooled estimate of controlled clinical trials.

Authors:  G Dobrilla; P Vallaperta; S Amplatz
Journal:  Gut       Date:  1988-02       Impact factor: 23.059

5.  Absorption and elimination of bismuth from oral doses of tripotassium dicitrato bismuthate.

Authors:  P R Froomes; A T Wan; A C Keech; J J McNeil; A J McLean
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

6.  An international multi-clinic study comparing the therapeutic efficacy of colloidal bismuth subcitrate coated tablets with chewing tablets in the treatment of duodenal ulceration.

Authors:  W Dekker; P R Dal Monte; G Bianchi Porro; N Van Bentem; J C Boekhorst; J P Crowe; T J Robinson; O Thys; A Van Driel
Journal:  Scand J Gastroenterol Suppl       Date:  1986

7.  Relative effectiveness and costs of antiulcer medications as a basis for rational prescribing.

Authors:  A J McLean; D M Harcourt; P G McCarthy; F J Dudley; J J McNeil
Journal:  Med J Aust       Date:  1987-04-20       Impact factor: 7.738

8.  Bismuth induced encephalopathy caused by tri potassium dicitrato bismuthate in a patient with chronic renal failure.

Authors:  R J Playford; C H Matthews; M J Campbell; H T Delves; K K Hla; H J Hodgson; J Calam
Journal:  Gut       Date:  1990-03       Impact factor: 23.059

9.  Bismuth accumulates in the body during treatment with tripotassium dicitrato bismuthate.

Authors:  C J Gavey; M L Szeto; C U Nwokolo; J Sercombe; R E Pounder
Journal:  Aliment Pharmacol Ther       Date:  1989-02       Impact factor: 8.171

Review 10.  Pharmacokinetics and toxicity of bismuth compounds.

Authors:  A Slikkerveer; F A de Wolff
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.